| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS10013776 | HBV | ENSG00000004468.13 | protein_coding | CD38 | No | No | 952 | P28907 |
| TVIS10013777 | HBV | ENSG00000004468.13 | protein_coding | CD38 | No | No | 952 | P28907 |
| TVIS10010803 | HBV | ENSG00000004468.13 | protein_coding | CD38 | No | No | 952 | P28907 |
| TVIS10012513 | HBV | ENSG00000004468.13 | protein_coding | CD38 | No | No | 952 | P28907 |
| TVIS10012614 | HBV | ENSG00000004468.13 | protein_coding | CD38 | No | No | 952 | P28907 |
| TVIS10013270 | HBV | ENSG00000004468.13 | protein_coding | CD38 | No | No | 952 | P28907 |
| TVIS10013469 | HBV | ENSG00000004468.13 | protein_coding | CD38 | No | No | 952 | P28907 |
| TVIS30074261 | HIV | ENSG00000004468.13 | protein_coding | CD38 | No | No | 952 | P28907 |
| TVIS44007007 | HTLV-1 | ENSG00000004468.13 | protein_coding | CD38 | No | No | 952 | P28907 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | CD38 |
|---|---|
| DrugBank ID | DB16370 |
| Drug Name | Mezagitamab |
| Target ID | BE0005459 |
| UniProt ID | P28907 |
| Regulation Type | inhibitor |
| PubMed IDs | 32045493 |
| Citations | Fedyk ER, Zhao L, Koch A, Smithson G, Estevam J, Chen G, Lahu G, Roepcke S, Lin J, Mclean L: Safety, tolerability, pharmacokinetics and pharmacodynamics of the anti-CD38 cytolytic antibody TAK-079 in healthy subjects. Br J Clin Pharmacol. 2020 Jul;86(7):1314-1325. doi: 10.1111/bcp.14241. Epub 2020 Feb 22. |
| Groups | Investigational |
| Direct Classification | Peptides |
| SMILES | |
| Pathways | |
| PharmGKB | |
| ChEMBL |
